Voice abnormalities and their relation with motor dysfunction in Parkinson's disease

Acta Neurologica Scandinavica

Volumn 117, Issue 1, 2008, Pages 26-34

  Midi, I ^a,e   Dogan, M ^b   Koseoglu, M ^a   Can, G ^c   Sehitoglu, M A ^d   Gunal, D I ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Department of Otorhinolaryngology Head and Neck Surgery ^*  (Turkey)

^e MARMARA UNIVERSITY   (Turkey)

Author keywords

Parkinson's disease; Unified Parkinson's Disease Rating Scale; Voice analysis

Indexed keywords

ACOUSTICS; ADULT; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPHONIA; FEMALE; HUMAN; LARYNX DISORDER; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERCEPTION; PHONATION; STATISTICAL SIGNIFICANCE; STROBOSCOPY; UNIFIED PARKINSON DISEASE RATING SCALE; VIDEOLARYNGOSTROBOSCOPY; VOICE;

AGED; DISABILITY EVALUATION; FEMALE; HOARSENESS; HUMANS; LARYNX; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUSCLE, SKELETAL; PARKINSON DISEASE; PHONATION; SEX CHARACTERISTICS; VOICE DISORDERS;

EID: 37249061262     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00965.x     Document Type: Article

References (30)

1. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998 51 (Suppl. 2 S2 9.
2. Bernheimer H, Birkmeyer W, Hornykiewicz O et al. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 1973 20 : 425 55.
3. Harel BT, Cannizzaro MS, Cohen H et al. Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment. J Neurolinguistics 2004 17 : 439 53.
4. Duffy JR. Motor speech disorders. Substrates, differential diagnosis and management (2nd edition). St Louis, MO : Elsevier Mosby, 2005.
5. Goberman AM. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease. Med Sci Monit 2005 11 : 109 16.
6. Goberman A, Coelho C, Robb M. Phonatory characteristics of Parkinsonian speech before and after morning medication: the ON and OFF states. J Commun Disord 2002 35 : 217 39.
7. Goberman A, Blomgren M. Parkinsonian speech disfluencies: effects of l-Dopa-related fluctuations. J Fluency Disord 2003 28 : 55 70.
8. Steiger M, Thompson P, Marsden C. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry 1996 61 : 645 8.
9. Bejjani B, Gervais D, Arnulf I et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2000 68 : 595 600.
10. Stebbins G, Goetz C. Factor structure of the Unified Parkinson's Disease Rating Scale: motor examination section. Mov Disord 1998 13 : 633 6.
11. Gamboa J, Jimenez-Jimenez FJ, Nieto A et al. Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs. J Voice 1997 11 : 314 20.
12. Sataloff RT, Heuer RJ, Emerich KA et al. Clinical voice laboratory. In : Sataloff RT, ed. The professional voice: the science and art of clinical care, 2nd edn. San Diego, CA : Singular Publishing Group, 1997 215 43.
13. Hirano M. Clinical examination of voice. New York : Springer Verlag, 1981.
14. Murry T, Rosen CA. Outcome measurements and quality of life in voice disorders. Otolaryngol Clin North Am 2000 33 : 905 16.
15. Baken RJ, Orlikoff RF. Airflow and volume. Clinical measurement of speech and voice. San Diego, CA : Singular Thomson Learning, 2000 337 91.
16. Baken RJ, Orlikoff RF. Speech movements. Clinical measurement of speech and voice. San Diego, CA : Singular Thomson Learning, 2000 542 47.
17. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In : Fahn S, Marsden C, Calne D, Goldstein M, eds. Recent developments in Parkinson's Disease, Vol. 2. Florham Park, NJ : Macmillan Health-Care Information 1987 153 63
18. De Letter M, Santens P, van Borsel J. The effects of levodopa on word intelligibility in Parkinson's disease. J Commun Disord 2005 28 : 187 96.
19. Spielman JL, Borod JC, Ramig LO. The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data. Cogn Behav Neurol. 2003 16 : 177 88.
20. Newman LA. Swallowing function in Parkinson's disease. In : Ebadi M, Pfeiffer RF eds. Parkinson's disease. Istanbul, Turkey : CRC Press Sigma Publishing 2005 785 90
21. Gallena S, Smith PJ, Zeffiro T et al. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. J Speech Lang Hear Res 2001 44 : 1284 99.
22. Stelzig Y, Hochhaus W, Gall V et al. Laryngeal manifestations in patients with Parkinson disease. Laryngorhinootologie 1999 78 : 544 51.
23. Perez KS, Ramig LO, Smith ME et al. Parkinson's larynx: tremor and videostroboscopic findings. J Voice 1996 10 : 354 61.
24. Doyle P, Raade A, St. Pierre A et al. Fundamental frequency and acoustic variability associated with production of sustained vowels by speakers with hypokinetic dysarthria. J Med Speech Lang Pathol 1995 3 : 41 50.
25. Mueller PB. Parkinson's disease: motor-speech behavior in a selected group of patients. Folia phoniatrica 1971 23 : 333 45.
26. Fox CM, Ramig LO. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 1997 6 : 85 94.
27. Sewall GK, Jiang J, Ford CN. Clinical evaluation of Parkinson's-related dysphonia. Laryngoscope 2006 116 : 1740 4.
28. Ackermann H, Konczak J, Hertrich I. The temporal control of repetitive articulatory movements in Parkinson's disease. Brain Lang 1997 57 : 312 9.
29. Pinto S, Ozsancak C, Tripoliti E et al. Treatments for dysarthria in Parkinson's disease. Lancet Neurol 2004 3 : 547 56.
30. Larson K, Ramig L, Scherer R. Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson disease. J Med Speech Lang Pathol 1994 2 : 227 39.